ArticleCureus2025
An Analysis of Male Breast Cancer Incidence, Mortality, and Disease Burden Among Commonwealth Countries.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mapping the invisible: a Bayesian spatio-temporal analysis of male breast cancer mortality inequalities across Spanish provinces, 1999-2023.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and aim Male breast cancer is a rare disease, and it remains inadequately researched globally. Due to its rarity and lack of widespread awareness, this disease often presents in an advanced stage, leading to higher mortality rates compared to the more common female breast cancer. Increasing age, the presence of genetic mutations, such as BRCA2, and exposure to certain hormonal and environmental factors have been cited as factors increasing the risk of this disease. This study aimed to investigate the incidence, death, and burden of male breast cancer, measured in years lived with disability (YLD) across the following three socioeconomic categories in the Commonwealth of Nations: high-, middle-, and low-income. Methods This study uses a retrospective cohort design to analyze data from the Global Burden of Disease (GBD) database from 1991 to 2021 to identify long-term trends and disparities. Descriptive statistics summarize breast cancer outcomes, while Analysis of Variance (ANOVA) and Tukey's honestly significant difference (HSD) tests identify significant differences across the socioeconomic categories. Findings Significant differences in male breast cancer incidence, mortality, and YLDs were found across the different socioeconomic categories. Middle-income Commonwealth regions had the highest incidence and mortality rates, whereas high-income regions had the lowest. These outcomes highlight the potential role of socioeconomic factors, wherein residents in high-income regions benefit from efficient early detection programs and advanced healthcare treatments, and policies. Conclusion In lower- and middle-class regions, there is a pressing need to improve the healthcare system and increase cancer awareness. The worldwide occurrence of advanced male breast cancer can be reduced by addressing these discrepancies through focused efforts to aid early detection, thereby improving prognoses. This study contributes to the limited body of literature regarding male breast cancer by highlighting the significance of socioeconomic factors on breast cancer outcomes and the need for equitable healthcare access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.